Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.7272
-0.0839 (-10.34%)
At close: Sep 17, 2026, 4:00 PM EDT
0.7201
-0.0071 (-0.98%)
After-hours: Sep 17, 2026, 5:27 PM EDT
Enlivex Employees
Enlivex had 34 employees as of December 31, 2025. The number of employees decreased by 37 or -52.11% compared to the previous year.
Employees
34
Change
-37
Growth
-52.11%
Revenue / Employee
n/a
Profits / Employee
$36,339,059
Market Cap
12.72M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 34 | -37 | -52.11% |
| Dec 31, 2021 | 71 | 21 | 42.00% |
| Dec 31, 2020 | 50 | 14 | 38.89% |
| Dec 31, 2019 | 36 | 5 | 16.13% |
| Dec 31, 2018 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Cerenome | 28 |
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| Lisata Therapeutics | 21 |
| Moleculin Biotech | 17 |
| BioVie | 13 |
| AEON Biopharma | 8 |
ENLV News
- 6 weeks ago - Enlivex Therapeutics registers to sell 10M ordinary shares for holders - TheFly
- 6 weeks ago - Enlivex Registration statement: Registration filing - Filings
- 6 weeks ago - Enlivex Therapeutics target adjusted to $80 from $20 at H.C. Wainwright - TheFly
- 7 weeks ago - Enlivex Transcript: Study update - Transcripts
- 7 weeks ago - Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June - GlobeNewsWire
- 7 weeks ago - Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones - GlobeNewsWire
- 7 weeks ago - Enlivex Therapeutics announces $400M private placement - TheFly
- 7 weeks ago - Enlivex Announces $400,000,000 Private Placement - GlobeNewsWire